222 related articles for article (PubMed ID: 9122243)
21. E4BP4/NFIL3, a PAR-related bZIP factor with many roles.
Cowell IG
Bioessays; 2002 Nov; 24(11):1023-9. PubMed ID: 12386933
[TBL] [Abstract][Full Text] [Related]
22. Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19).
Hirose K; Inukai T; Kikuchi J; Furukawa Y; Ikawa T; Kawamoto H; Oram SH; Göttgens B; Kiyokawa N; Miyagawa Y; Okita H; Akahane K; Zhang X; Kuroda I; Honna H; Kagami K; Goi K; Kurosawa H; Look AT; Matsui H; Inaba T; Sugita K
Blood; 2010 Aug; 116(6):962-70. PubMed ID: 20519628
[TBL] [Abstract][Full Text] [Related]
23. Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia.
Hunger SP; Ohyashiki K; Toyama K; Cleary ML
Genes Dev; 1992 Sep; 6(9):1608-20. PubMed ID: 1516826
[TBL] [Abstract][Full Text] [Related]
24. Two types of genomic rearrangements create alternative E2A-HLF fusion proteins in t(17;19)-ALL.
Hunger SP; Devaraj PE; Foroni L; Secker-Walker LM; Cleary ML
Blood; 1994 May; 83(10):2970-7. PubMed ID: 8180393
[TBL] [Abstract][Full Text] [Related]
25. Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice.
Smith KS; Rhee JW; Naumovski L; Cleary ML
Mol Cell Biol; 1999 Jun; 19(6):4443-51. PubMed ID: 10330184
[TBL] [Abstract][Full Text] [Related]
26. Up-regulation of survivin by the E2A-HLF chimera is indispensable for the survival of t(17;19)-positive leukemia cells.
Okuya M; Kurosawa H; Kikuchi J; Furukawa Y; Matsui H; Aki D; Matsunaga T; Inukai T; Goto H; Altura RA; Sugita K; Arisaka O; Look AT; Inaba T
J Biol Chem; 2010 Jan; 285(3):1850-60. PubMed ID: 19887369
[TBL] [Abstract][Full Text] [Related]
27. E2A-HLF usurps control of evolutionarily conserved survival pathways.
Seidel MG; Look AT
Oncogene; 2001 Sep; 20(40):5718-25. PubMed ID: 11607821
[TBL] [Abstract][Full Text] [Related]
28. The CES-2-related transcription factor E4BP4 is an intrinsic regulator of motoneuron growth and survival.
Junghans D; Chauvet S; Buhler E; Dudley K; Sykes T; Henderson CE
Development; 2004 Sep; 131(18):4425-34. PubMed ID: 15306565
[TBL] [Abstract][Full Text] [Related]
29. Antagonistic role of E4BP4 and PAR proteins in the circadian oscillatory mechanism.
Mitsui S; Yamaguchi S; Matsuo T; Ishida Y; Okamura H
Genes Dev; 2001 Apr; 15(8):995-1006. PubMed ID: 11316793
[TBL] [Abstract][Full Text] [Related]
30. Transcriptional repression by the human bZIP factor E4BP4: definition of a minimal repression domain.
Cowell IG; Hurst HC
Nucleic Acids Res; 1994 Jan; 22(1):59-65. PubMed ID: 8127655
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the DBP promoter by PAR proteins and in leukemic cells bearing an E2A/HLF translocation.
Newcombe K; Glassco T; Mueller C
Biochem Biophys Res Commun; 1998 Apr; 245(2):633-9. PubMed ID: 9571207
[TBL] [Abstract][Full Text] [Related]
32. DNA-binding specificity of the PAR basic leucine zipper protein VBP partially overlaps those of the C/EBP and CREB/ATF families and is influenced by domains that flank the core basic region.
Haas NB; Cantwell CA; Johnson PF; Burch JB
Mol Cell Biol; 1995 Apr; 15(4):1923-32. PubMed ID: 7891686
[TBL] [Abstract][Full Text] [Related]
33. Identification of Zfp521/ZNF521 as a cooperative gene for E2A-HLF to develop acute B-lineage leukemia.
Yamasaki N; Miyazaki K; Nagamachi A; Koller R; Oda H; Miyazaki M; Sasaki T; Honda ZI; Wolff L; Inaba T; Honda H
Oncogene; 2010 Apr; 29(13):1963-75. PubMed ID: 20062079
[TBL] [Abstract][Full Text] [Related]
34. Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia.
Inaba T; Roberts WM; Shapiro LH; Jolly KW; Raimondi SC; Smith SD; Look AT
Science; 1992 Jul; 257(5069):531-4. PubMed ID: 1386162
[TBL] [Abstract][Full Text] [Related]
35. Regulation of annexin II by cytokine-initiated signaling pathways and E2A-HLF oncoprotein.
Matsunaga T; Inaba T; Matsui H; Okuya M; Miyajima A; Inukai T; Funabiki T; Endo M; Look AT; Kurosawa H
Blood; 2004 Apr; 103(8):3185-91. PubMed ID: 15070701
[TBL] [Abstract][Full Text] [Related]
36. Identification of multiple transcription factors, HLF, FTF, and E4BP4, controlling hepatitis B virus enhancer II.
Ishida H; Ueda K; Ohkawa K; Kanazawa Y; Hosui A; Nakanishi F; Mita E; Kasahara A; Sasaki Y; Hori M; Hayashi N
J Virol; 2000 Feb; 74(3):1241-51. PubMed ID: 10627534
[TBL] [Abstract][Full Text] [Related]
37. Two candidate downstream target genes for E2A-HLF.
Kurosawa H; Goi K; Inukai T; Inaba T; Chang KS; Shinjyo T; Rakestraw KM; Naeve CW; Look AT
Blood; 1999 Jan; 93(1):321-32. PubMed ID: 9864177
[TBL] [Abstract][Full Text] [Related]
38. Expression patterns of the hepatic leukemia factor gene in the nervous system of developing and adult mice.
Hitzler JK; Soares HD; Drolet DW; Inaba T; O'Connel S; MG Rosenfeld ; Morgan JI; Look AT
Brain Res; 1999 Feb; 820(1-2):1-11. PubMed ID: 10023025
[TBL] [Abstract][Full Text] [Related]
39. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1.
Hu HM; Tian Q; Baer M; Spooner CJ; Williams SC; Johnson PF; Schwartz RC
J Biol Chem; 2000 May; 275(21):16373-81. PubMed ID: 10748205
[TBL] [Abstract][Full Text] [Related]
40. The transcription factor NFIL3/E4BP4 regulates the developmental stage-specific acquisition of basophil function.
Park J; Cho Y; Yang D; Yang H; Lee D; Kubo M; Kang SJ
J Allergy Clin Immunol; 2024 Jan; 153(1):132-145. PubMed ID: 37783432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
